azelaic bishydroxamic acid has been researched along with hexamethylene bisacetamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ablett, EM; Danoy, PA; Dunn, IS; Fairlie, DP; Hansen, C; Parsons, PG; Pedley, J; Sturm, RA; West, ML | 1 |
| Andrews, KT; Fairlie, DP; Kelso, MJ; Parsons, PG; Saul, A; Walduck, A | 1 |
2 other study(ies) available for azelaic bishydroxamic acid and hexamethylene bisacetamide
| Article | Year |
|---|---|
Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells.
Topics: Acetamides; Antineoplastic Agents; Cell Line; Cell Line, Transformed; Cell Survival; Dicarboxylic Acids; Genes, Reporter; Humans; Hydroxamic Acids; Interferon Type I; Melanocytes; Membrane Glycoproteins; Monophenol Monooxygenase; Oxidoreductases; Proteins; Signal Transduction; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents.
Topics: Acetamides; Animals; Antimalarials; Antineoplastic Agents; Azacitidine; Cell Differentiation; DNA Methylation; Enzyme Inhibitors; Female; Hematinics; Histone Deacetylase Inhibitors; Hydroxamic Acids; Mice; Mice, Inbred BALB C; Plasmodium berghei; Plasmodium falciparum | 2000 |